Griffith University Launches XR4Kids Study on Extended Reality in Pediatric Cancer Care

Griffith University’s School of Nursing and Midwifery has initiated the XR4Kids study, led by Dr. Karin Plummer, to examine the application of extended reality (XR) technologies in pediatric cancer care. The research aims to gather insights from families and clinicians regarding their experiences with XR, identify current access barriers, and investigate methods for its safe and sustainable integration to support children undergoing cancer treatment.

Study Objectives

The XR4Kids study has several key objectives designed to advance the understanding and application of XR in a sensitive care context:

• To understand the experiences of families and clinicians concerning extended reality technologies in pediatric cancer care.
• To identify existing barriers to accessing XR technologies within this context.
• To explore safe and sustainable methods for integrating XR to support children throughout their cancer treatment.

Background and Rationale

Currently, virtual reality (VR), a form of XR, is utilized in some hospitals. However, its access is inconsistent, and it is not routinely integrated into standard cancer treatment pathways. Cancer treatment can have significant long-term physical and psychological impacts on children. XR technologies are being explored as a potential tool to assist in managing pain and distress by redirecting a patient's attention.

Dr. Plummer stated that the study aims to explore non-invasive methods for pain reduction in children during cancer care. She noted that virtual reality can immerse children in engaging experiences, potentially diverting their attention from pain, which may offer comfort and a sense of control in conjunction with standard medical care. A further objective of the study is to ensure the technology is practical and easy for clinicians to use.

Participant Information

The research seeks diverse participation to gain comprehensive insights into XR's potential in pediatric cancer care:

• Families, children, and young people aged 8-18 years with lived experience of childhood cancer treatment.
• Healthcare professionals who have experience with or interest in using XR in children’s cancer care.

Participants from across the country are invited to contribute to the study by joining an online community or by participating in online interviews.

Study Timeline

The XR4Kids study is scheduled to run from March 9 to March 16.